Home›Companies›Biotech & Pharma›Sonalasense

Sonalasense, Inc.

Updated Oct 27, 2026·Latest SEC filing Nov 6, 2023·Suggest an edit

About Sonalasense

Sonalasense is a private company based in Oakland, California, incorporated in 2019 in New York. It has reported $34,791,582 raised in four offerings on Form D since September 2020. Its chief executive is Mark De Souza.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 21, 2023Nov 6, 2023$9,765,000of $15.0M target30$325KDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Dec 29, 2021Jan 10, 2022$20,093,202of $30.0M target30$669KEquityRule 506(b)Form D ↗
Feb 1, 2021Feb 11, 2021$3,933,400of $7.9M target26$151KEquityRule 506(b)Form D ↗
Dec 9, 2019Sep 30, 2020$999,980of $2.0M target13$76,922DebtRule 506(b)Form D ↗
Total, four offerings$34,791,582

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sonalasense's Form D filed Nov 6, 2023.

MS
Mark De Souza
President & CEO, director
SM
Stuart Marcus
Executive officer and director
VS
Vincent Sai
Director

Sources

  1. SECSONALASENSE, INC. filing history